Biogen (BIIB) PT Lowered to $280 at RBC Capital

January 30, 2020 1:09 PM EST Send to a Friend

RBC Capital analyst Brian Abrahams lowered the price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Biogen (BIIB) PT Lowered to $280 at RBC Capital

Member Login

Free News Feed